Coronary Artery Disease

Clinical Trial Finder

Many patients with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Conditions:   Ebola Virus Disease;   Hemorrhagic Fever
Interventions:   Biological: VRC-EBOADC069-00-vp;   Biological: VRC-EBOADC069-00-vp
Sponsors:   University of Maryland;   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2015

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease

Condition:   Cardiovascular Disease
Interventions:   Drug: Aspirin;   Drug: Durlaza™
Sponsor:   New Haven Pharmaceuticals, Inc.
Recruiting - verified February 2015

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES

Condition:   Coronary Restenosis
Intervention:   Device: PCB
Sponsor:   Deutsches Herzzentrum Muenchen
Recruiting - verified February 2015

Very Brief Smoking Reduction Intervention

Condition:   Smoking Cessation
Interventions:   Behavioral: Smoking reduction intervention;   Behavioral: Exercise and diet advice control
Sponsor:   Chinese PLA General Hospital
Not yet recruiting - verified February 2015

Stress Echocardiography Versus Exercise ECG in Women With Chest Pain

Condition:   Coronary Artery Disease
Interventions:   Procedure: Exercise ECG;   Procedure: Stress Echocardiography
Sponsor:   London North West Healthcare NHS Trust
Recruiting - verified February 2015

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

Conditions:   Obesity;   Fatty Liver, Nonalcoholic
Intervention:   Drug: pitavastatin
Sponsor:   Massachusetts General Hospital
Recruiting - verified February 2015

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Condition:   Cardiogenic Shock
Intervention:   Device: HeartMate PHP
Sponsor:   Thoratec Corporation
Recruiting - verified February 2015

Computed Tomography (CT) Coronary Angiogram Evaluation in Cancer Patients Having CT Thorax, Abdomen and Pelvis

Condition:   Coronary Stenosis
Intervention:   Radiation: CT TAP Scan
Sponsor:   Plymouth Hospitals NHS Trust
Not yet recruiting - verified February 2015

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Conditions:   Stroke;   Secondary Prevention
Interventions:   Drug: optional ASA as comedication;   Drug: placebo to ASA;   Drug: placebo to optional ASA as comedication;   Drug: placebo to dabigatran etexilate;   Drug: ASA 100 mg;   Drug: dabigatran etexilate
Sponsor:   Boehringer Ingelheim
Recruiting - verified February 2015

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction

Conditions:   ST-segment Elevation Myocardial Infarction;   Non-ST-segment Elevation Myocardial Infarction;   VA Drug Interactions [VA Drug Interaction]
Interventions:   Drug: Morphine;   Drug: Placebo;   Drug: Ticagrelor
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified February 2015

Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program

Conditions:   Coronary Artery Disease;   Myocardial Infarction
Interventions:   Other: Interval exercise training;   Other: Continuous exercise training
Sponsor:   Assaf-Harofeh Medical Center
Recruiting - verified February 2015

Paraoxonase and HDL Qualities in Glycaemia and Inflammation

Conditions:   Diabetes.;   Bariatric Surgery.
Intervention:  
Sponsors:   Central Manchester University Hospitals NHS Foundation Trust;   British Heart Foundation;   Juvenile Diabetes Research Foundation
Recruiting - verified February 2015

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Losmapimod 7.5 mg twice daily;   Drug: Placebo twice daily
Sponsors:   GlaxoSmithKline;   The TIMI Study Group
Recruiting - verified February 2015

Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

Conditions:   Hypertensive Disease;   Hypertension, Resistant to Conventional Therapy
Intervention:  
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified February 2015

Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management

Conditions:   Overweight;   Obese
Interventions:   Device: LLLT;   Drug: Lorcaserin
Sponsor:   Mayo Clinic
Active, not recruiting - verified February 2015

EARly Prevention of aTHeroma Progression

Condition:   Coronary Arteriosclerosis
Interventions:   Behavioral: Standard Therapy;   Drug: Rosuvastatin
Sponsors:   CHEOL WHAN LEE, M.D., Ph.D;   CardioVascular Research Foundation, Korea
Recruiting - verified February 2015

Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function

Condition:   ST-Segment Elevation Myocardial Infarction
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   Jinan Central Hospital
Not yet recruiting - verified February 2015

A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.

Condition:   Acute Myocardial Infarction
Interventions:   Biological: CSL112;   Biological: Placebo
Sponsor:   CSL Behring
Recruiting - verified February 2015

A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:

Condition:   Coronary Artery Disease
Interventions:   Drug: Prasugrel;   Drug: Ticagrelor
Sponsor:   University of Florida
Recruiting - verified February 2015

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

Conditions:   Aortic Valve Disease;   Coronary Artery Disease (CAD)
Interventions:   Drug: Custodiol-N;   Drug: Custodiol
Sponsor:   Dr. F. Köhler Chemie GmbH
Recruiting - verified February 2015

A Phase II Study of Androgen Deprivation Therapy With or Without PD 0332991 in RB-Positive Metastatic Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: PD 0332991;   Drug: Bicalutamide;   Drug: Zoladex;   Drug: Lupron Depot
Sponsors:   University of Michigan Cancer Center;   University of Utah;   Vanderbilt-Ingram Cancer Center;   Dana-Farber Cancer Institute;   Johns Hopkins University;   Thomas Jefferson University
Recruiting - verified February 2015

Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.

Condition:   Non-ST Elevation Acute Coronary Syndrome
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   AstraZeneca
Recruiting - verified February 2015

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Ticagrelor 90 mg;   Drug: Ticagrelor placebo
Sponsor:   AstraZeneca
Recruiting - verified February 2015

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis

Condition:   Coronary Artery Stenosis
Interventions:   Device: BioNIR;   Device: Resolute
Sponsor:   Medinol Ltd.
Recruiting - verified February 2015

Prophylactic IABP in High-risk Patients Undergoing CABG

Conditions:   Myocardial Infarction;   Coronary Artery Disease
Intervention:   Procedure: Preoperative IABC
Sponsor:   University of Giessen
Not yet recruiting - verified February 2015

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   HeartFlow, Inc.;   Duke Clinical Research Institute
Active, not recruiting - verified February 2015

The PzF Shield Trial

Condition:   Coronary Artery Disease
Intervention:   Device: COBRA PzF
Sponsor:   CeloNova BioSciences, Inc.
Active, not recruiting - verified February 2015

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified February 2015

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

Condition:   Hiv Infection
Intervention:   Biological: blood sampling,
Sponsor:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - verified February 2015

Renal Denervation in Patients After Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   Arterial Hypertension
Interventions:   Procedure: Renal denervation;   Drug: Metoprolol;   Drug: Lisinopril
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified February 2015

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Conditions:   Heart Failure;   Coronary Artery Disease
Interventions:   Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified February 2015

The Effectiveness of the Care Programme for the Last Days of Life

Condition:   Older Patients Dying in Acute Geriatric Hospital Wards
Intervention:   Other: Care Programme for the Last Days of Life
Sponsors:   End-of-Life Research Group;   Agentschap voor Innovatie door Wetenschap en Technologie;   Katholieke Universiteit Leuven;   VU University Medical Center;   University Ghent;   Vrije Universiteit Brussel
Recruiting - verified February 2015

Optimum Treatment for Drug-Resistant Hypertension

Condition:   Hypertension, Resistant to Conventional Therapy
Interventions:   Drug: Spironolactone;   Drug: Bisoprolol;   Drug: Doxazosin;   Drug: Placebo
Sponsors:   University of Cambridge;   British Heart Foundation
Active, not recruiting - verified February 2015

The TRUST Study - Depression Substudy

Conditions:   Subclinical Hypothyroidism;   Depression
Interventions:   Drug: Levothyroxine;   Drug: Placebo
Sponsors:   University Hospital Inselspital, Berne;   Leiden University Medical Center;   University of Bern
Recruiting - verified February 2015

Cerebral Oximetry and Perioperative Outcome in Non-Cardiac Surgery

Conditions:   High Risk Non-cardiac Surgery;   Death;   Delirium;   Kidney Injury;   Myocardial Infarction;   Respiratory Failure;   Postoperative Infection
Intervention:   Other: Observational study
Sponsors:   University of Manitoba;   Canadian Anesthesia Research Foundation
Recruiting - verified February 2015

Parasternal Nerve Block in Cardiac Patients

Conditions:   Coronary Artery Disease;   Pain, Postoperative
Interventions:   Drug: Exparel;   Drug: Placebo
Sponsor:   Peter A Knight
Recruiting - verified February 2015

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

Conditions:   Coronary Artery Disease;   Ischemic Heart Disease
Intervention:   Device: Drug-eluting stent
Sponsor:   Odense University Hospital
Recruiting - verified February 2015

Cardiac GSI Feasibility Study

Condition:   High Risk of Significant Coronary Artery Disease
Intervention:   Device: Cardiac GSI
Sponsor:   Plymouth Hospitals NHS Trust
Recruiting - verified February 2015

Canadian Ticagrelor Survey

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Completed - verified February 2015

Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease

Condition:   Refractory Cold Agglutinin Disease
Intervention:   Drug: Bortezomib
Sponsor:   Gruppo Italiano Malattie EMatologiche dell'Adulto
Recruiting - verified February 2015

The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease

Conditions:   Myocardial Infarction;   Unstable Angina
Intervention:  
Sponsors:   Massachusetts General Hospital;   University of California, Berkeley
Completed - verified February 2015

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: alirocumab SAR236553 (REGN727);   Other: placebo
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Recruiting - verified February 2015

Tryptase and Coronary Heart Disease

Conditions:   Acute Coronary Syndrome With ST Elevation on Electrocardiogram;   Acute Coronary Syndrome Without ST Elevation on Electrocardiogram;   Noncritical Coronary Artery Disease With Coronary Stenosis <50%;   Aortic Aneurysms
Intervention:  
Sponsor:   Niguarda Hospital
Recruiting - verified February 2015

A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial Surgery

Conditions:   Tachycardia;   Hypertension;   Myocardial Ischemia
Interventions:   Drug: Esmolol;   Drug: Remifentanil
Sponsor:   Diskapi Teaching and Research Hospital
Completed - verified December 2012

Coronary Artery Bypass Grafting Strategies for the Anterolateral Territory: a Prospective Randomized Clinical Trial

Condition:   Coronary Artery Disease
Interventions:   Procedure: LIMA to SVG Bridge Technique;   Procedure: Conventional CABG
Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified February 2015

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Modification of Prasugrel based on a biological assay;   Drug: prasugrel / clopidogrel;   Device: Verify Now
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Eli Lilly and Company;   Daiichi Sankyo Inc.;   Allies in Cardiovascular Trials Initiatives and Organized Networks:ACTION;   Accumetrics, Inc.;   Stentys
Recruiting - verified February 2015

Primary Reperfusion Secondary Stenting Trial

Condition:   ST-elevation Myocardial Infarction
Intervention:   Procedure: Percutaneous coronary intervention
Sponsor:   Montreal Heart Institute
Recruiting - verified February 2015

Radial Artery Access With Ultrasound Trial

Condition:   Coronary Artery Disease
Interventions:   Procedure: Ultrasound guidance;   Procedure: Palpation
Sponsors:   University of California, Irvine;   Lenox Hill Hospital;   Jamaica Hospital Medical Center;   Oklahoma City VA Medical Center
Completed - verified February 2015

Age-Related Changes in Body Composition

Conditions:   Hypertension;   Atherosclerosis
Intervention:  
Sponsor:   National Institute on Aging (NIA)
Recruiting - verified January 2015

A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Condition:   Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions:   Other: Background care;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention

Conditions:   Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina
Interventions:   Drug: Short Tirofiban;   Drug: Eptifibatide;   Drug: Long Tirofiban
Sponsors:   Medicure;   SCRI Development Innovations, LLC
Recruiting - verified February 2015

The eSVS® Mesh Post-Marketing Trial

Conditions:   Coronary Artery Disease;   Myocardial Ischemia;   Coronary Disease;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Intervention:   Device: eSVS Mesh
Sponsors:   Kips Bay Medical, Inc.;   University Hospital, Basel, Switzerland
Active, not recruiting - verified February 2015

Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

Condition:   Coronary Artery Disease (CAD)
Interventions:   Procedure: LIMA-LAD surgical revascularization;   Procedure: PCI
Sponsor:   Ettore Sansavini Health Science Foundation
Recruiting - verified February 2015

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Conditions:   Coronary Artery Disease;   Angina Pectoris
Interventions:   Drug: Ranolazine;   Drug: Placebo
Sponsor:   Gilead Sciences
Completed - verified February 2015

Management of New-Onset Postoperative Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Coronary Artery Disease;   Post Operative Arrythmia
Intervention:  
Sponsors:   Emory University;   Medtronic
Recruiting - verified February 2015

"ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction

Conditions:   Acute Myocardial Infarction;   Heart Failure
Intervention:   Procedure: PCI and Stem Cells or Placebo injections
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified February 2015

REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Drug: Aspirin 200mg qd, Clopidogrel 2x75mg qd
Sponsor:   University Hospital Ostrava
Recruiting - verified February 2015

A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention

Condition:   Myocardial Infarction
Interventions:   Procedure: Percutaneous Coronary Intervention (PCI);   Drug: RO4905417;   Drug: RO4905417;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

Imaging and Biomarkers of Atherosclerosis in Patients With Stable or Unstable Coronary Artery Disease

Conditions:   Atherosclerosis;   Coronary Artery Disease;   Acute Coronary Syndrome
Interventions:   Device: Coronary intervention using IVUS-VH & FDG PET-MDCT;   Device: Coronary intervention using IVUS-VH & FDG PET-MDCT
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Institut National de la Santé Et de la Recherche Médicale, France
Completed - verified February 2015

Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study.

Conditions:   Atrial Fibrillation;   Peripheral Vascular Disease
Intervention:  
Sponsor:   University of Roma La Sapienza
Completed - verified February 2015

Physiopathology of Rapid Aspirin Desensitization

Conditions:   Hypersensitivity;   Coronary Artery Disease
Intervention:  
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed - verified February 2015

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Condition:   Cardiovascular Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Terminated - verified February 2015

Non-Contact Measurement of Aortic Compliance

Condition:   Vascular Disease
Intervention:  
Sponsors:   Barts & The London NHS Trust;   National Institute for Health Research, United Kingdom
Completed - verified February 2015

Aerobic Interval Training in Cardiac Rehabilitation

Conditions:   Myocardial Infarction;   Coronary Artery Disease
Intervention:   Other: Exercise training
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital
Completed - verified February 2015

Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients With Prior Equivocal Stress Test for Detection of Coronary Artery Disease

Conditions:   Myocardial Ischemia;   Coronary Artery Disease;   Myocardial Infarction
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2015

Cardiovascular Disease Study

Condition:   Spinal Cord Injury
Interventions:   Procedure: 2 hour Oral Glucose Tolerance Test;   Procedure: Fat Meal Test
Sponsors:   Department of Veterans Affairs;   Kessler Foundation
Recruiting - verified February 2015

French Registry of Acute Coronary Syndrome

Condition:   Acute Myocardial Infarction
Intervention:   Other: Blood sample
Sponsors:   Assistance Publique - Hôpitaux de Paris;   French Cardiology Society
Active, not recruiting - verified October 2014

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Condition:   Coronary Heart Disease
Interventions:   Drug: Evidence-based medical care for Acute Coronary Syndrome;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

Database Registry of the Intermountain Heart Collaborative Study

Conditions:   Coronary Artery Disease;   Electrophysiology;   Cardiovascular Disease
Intervention:  
Sponsor:   Intermountain Health Care, Inc.
Recruiting - verified February 2015

A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified February 2015

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Conditions:   Hypercholesterolemia;   Coronary Disease
Interventions:   Drug: MK0653, ezetimibe;   Drug: Comparator: ezetimibe, placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified February 2015

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Conditions:   Hypercholesterolemia;   Coronary Disease
Interventions:   Drug: MK0653, ezetimibe;   Drug: Comparator: ezetimibe, placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified February 2015

Behavioral Factors in Coronary Heart Disease

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Metabolic Syndrome X
Intervention:  
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2015

Get CardioSmart

You're Invited